Max Robotics — Global Service Robot Directory + US Certification

About

Gerjon Hannink is a leading researcher in surgical outcomes and learning curve analysis, with a focus on minimally invasive and robot-assisted procedures in urology and pancreatic surgery. His work has profoundly influenced how surgeons and institutions adopt complex techniques, particularly through multicenter studies that provide robust, generalizable evidence. Hannink’s most-cited paper, a 2021 comparative effectiveness study on robot-assisted versus open radical cystectomy for bladder cancer (53 citations), demonstrates his commitment to evaluating real-world outcomes and economic implications—a companion cost analysis (16 citations) further underscores this impact. He is especially recognized for pioneering learning curve research: his 2023 study on minimally invasive distal pancreatectomy (40 citations) and a 2022 analysis of intracorporeal robot-assisted radical cystectomy (40 citations) have become essential references for reducing patient harm during surgical transitions. By quantifying how experience affects complication rates and oncologic results—such as in his 2018 work on positive surgical margins after prostatectomy (19 citations)—Hannink provides actionable insights that guide training and quality improvement. His collaborative, evidence-driven approach makes him a vital voice in modern surgical innovation, helping to safely accelerate the adoption of advanced techniques worldwide.